Aarey Drugs strengthens on securing first commercial export order

09 May 2017 Evaluate

Aarey Drugs & Pharmaceuticals is currently trading at Rs. 107.00, up by 2.40 points or 2.29% from its previous closing of Rs. 104.60 on the BSE.

The scrip opened at Rs. 108.00 and has touched a high and low of Rs. 108.00 and Rs. 105.00 respectively. So far 98435 shares were traded on the counter.

The BSE group 'XT' stock of face value Rs. 10 has touched a 52 week high of Rs. 109.80 on 28-Apr-2017 and a 52 week low of Rs. 36.00 on 10-May-2016.

Last one week high and low of the scrip stood at Rs. 108.80 and Rs. 101.10 respectively. The current market cap of the company is Rs. 193.42 crore.

The promoters holding in the company stood at 53.40%, while Non-Institutions held 46.60% stake in the company.

Aarey Drugs & Pharmaceuticals has received its first commercial export order for 20 metric tones of Thiobromine from Germany. The order will be executed by June 30, 2017. 

Aarey Drugs & Pharmaceuticals is engaged in the manufacturing of drugs and intermediates such as metronidazole, metronidazole benzoate, methyl, and nitro imidazole. The company is based in Thane, India.

Aarey Drugs & Pharma Share Price

63.46 1.61 (2.60%)
01-Nov-2024 18:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1858.70
Dr. Reddys Lab 1258.55
Cipla 1559.20
Lupin 2198.25
Zydus Lifesciences 1004.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.